|
Abraxis BioScience Launches Abraxane(R) In European Union
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced the launch in the European Union of Abraxane® Paclitaxel 5 mg/ml powder for suspension for infusion. Abraxane® is an albumin-bound nanoparticle formulation of paclitaxel.
More... |
| All times are GMT -7. The time now is 06:34 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021